These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 11901152)
1. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV. Richard E; Alam SM; Arredondo-Vega FX; Patel DD; Hershfield MS J Biol Chem; 2002 May; 277(22):19720-6. PubMed ID: 11901152 [TBL] [Abstract][Full Text] [Related]
2. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency. Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872 [TBL] [Abstract][Full Text] [Related]
3. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of CD26/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface. Weihofen WA; Liu J; Reutter W; Saenger W; Fan H J Biol Chem; 2004 Oct; 279(41):43330-5. PubMed ID: 15213224 [TBL] [Abstract][Full Text] [Related]
5. 3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis. Ludwig K; Fan H; Dobers J; Berger M; Reutter W; Böttcher C Biochem Biophys Res Commun; 2004 Jan; 313(2):223-9. PubMed ID: 14684150 [TBL] [Abstract][Full Text] [Related]
6. Cell surface adenosine deaminase binds and stimulates plasminogen activation on 1-LN human prostate cancer cells. Gonzalez-Gronow M; Hershfield MS; Arredondo-Vega FX; Pizzo SV J Biol Chem; 2004 May; 279(20):20993-8. PubMed ID: 15016824 [TBL] [Abstract][Full Text] [Related]
7. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain. Abbott CA; McCaughan GW; Levy MT; Church WB; Gorrell MD Eur J Biochem; 1999 Dec; 266(3):798-810. PubMed ID: 10583373 [TBL] [Abstract][Full Text] [Related]
8. Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase. Jeanfavre DD; Woska JR; Pargellis CA; Kennedy CA; Prendergast J; Stearns C; Reilly PL; Barton RW; Bormann BJ Biochem Pharmacol; 1996 Dec; 52(11):1757-65. PubMed ID: 8986139 [TBL] [Abstract][Full Text] [Related]
9. On the regulatory role of dipeptidyl peptidase IV (=CD=adenosine deaminase complexing protein) on adenosine deaminase activity. Ben-Shooshan I; Kessel A; Ben-Tal N; Cohen-Luria R; Parola AH Biochim Biophys Acta; 2002 May; 1587(1):21-30. PubMed ID: 12009420 [TBL] [Abstract][Full Text] [Related]
10. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406 [TBL] [Abstract][Full Text] [Related]
11. Regulation of adenosine receptor engagement by ecto-adenosine deaminase. Hashikawa T; Hooker SW; Maj JG; Knott-Craig CJ; Takedachi M; Murakami S; Thompson LF FASEB J; 2004 Jan; 18(1):131-3. PubMed ID: 14630704 [TBL] [Abstract][Full Text] [Related]
12. Binding of adenosine deaminase to the lymphocyte surface via CD26. De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293 [TBL] [Abstract][Full Text] [Related]
13. The structure and function of CD26 in the T-cell immune response. Morimoto C; Schlossman SF Immunol Rev; 1998 Feb; 161():55-70. PubMed ID: 9553764 [TBL] [Abstract][Full Text] [Related]
14. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase. Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383 [TBL] [Abstract][Full Text] [Related]
15. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233 [TBL] [Abstract][Full Text] [Related]
16. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5). de Meester I; Vanhoof G; Lambeir AM; Scharpé S J Immunol Methods; 1996 Jan; 189(1):99-105. PubMed ID: 8576585 [TBL] [Abstract][Full Text] [Related]
17. Crystal structures of HIV-1 Tat-derived nonapeptides Tat-(1-9) and Trp2-Tat-(1-9) bound to the active site of dipeptidyl-peptidase IV (CD26). Weihofen WA; Liu J; Reutter W; Saenger W; Fan H J Biol Chem; 2005 Apr; 280(15):14911-7. PubMed ID: 15695814 [TBL] [Abstract][Full Text] [Related]
18. Distribution and expression of A1 adenosine receptors, adenosine deaminase and adenosine deaminase-binding protein (CD26) in goldfish brain. Beraudi A; Traversa U; Villani L; Sekino Y; Nagy JI; Poli A Neurochem Int; 2003 May; 42(6):455-64. PubMed ID: 12547644 [TBL] [Abstract][Full Text] [Related]
19. The CP-I subunit of adenosine deaminase complexing protein from calf kidney is identical to human, mouse, and rat dipeptidyl peptidase IV. Ben-Shooshan I; Parola AH Comp Biochem Physiol B Biochem Mol Biol; 1998 Feb; 119(2):289-92. PubMed ID: 9629661 [TBL] [Abstract][Full Text] [Related]
20. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Ginés S; Mariño M; Mallol J; Canela EI; Morimoto C; Callebaut C; Hovanessian A; Casadó V; Lluis C; Franco R Biochem J; 2002 Jan; 361(Pt 2):203-9. PubMed ID: 11772392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]